|
Featured Stories
|
|
1 - 20 of 79
Articles
|
|
Thursday, 25 Feb 2010
Study published in HeartRhythm Journal shows female patients undergo catheter ablation less often and experience more complications than males [more]
|
|
|
Friday, 22 Jan 2010
An overview of clinical trials on AF ablation devices seeking FDA approval was presented by Hugh Calkins, Johns Hopkins Hospital, Baltimore, USA, at the Boston AF Symposium. [more]
|
|
|
Friday, 22 Jan 2010
Results of the ACTIVE A and RE-LY trials were presented by Stuart Connolly, McMaster University, Hamilton, Canada, at the Boston AF Symposium. [more]
|
|
|
Friday, 22 Jan 2010
New observations from the Second Worldwide Survey on AF Ablation showed that more procedures are being offered every year. [more]
|
|
|
Monday, 18 Jan 2010
New study will revisit patients from the groundbreaking SCD-HeFT trial to collect long-term data regarding the efficacy of ICDs in heart failure patients. [more]
|
|
|
Thursday, 14 Jan 2010
Under the terms of the agreement, Biotronik will be the exclusive distributor of the TactiCath in all major markets outside of the United States, Japan and Asia. [more]
|
|
|
Tuesday, 12 Jan 2010
The FDA also approved all magnetic catheters for use with newly increased field strength for magnetic navigation. [more]
|
|
|
Monday, 11 Jan 2010
“The evidence provided to the independent appraisal committee indicates that dronedarone is less effective and costs considerably more than existing treatments for controlling AF,” the agency wrote. [more]
|
|
|
Thursday, 07 Jan 2010
Diagnostic device for complete wireless remote patient monitoring is compatible with the Biotronik Home Monitoring. [more]
|
|
|
Friday, 04 Dec 2009
Enhanced visibility and performance features help physicians dilate scar tissue surrounding problematic cardiac leads requiring removal. [more]
|
|
|
Monday, 30 Nov 2009
Multaq, developed by Sanofi-aventis, is the first new anti-arrhythmic drug to be approved in Europe in the last 10 years. [more]
|
|
|
Monday, 09 Nov 2009
Cognis cardiac resynchronisation therapy defibrillator and Teligen implantable cardioverter defibrillator are the world’s smallest and thinnest high-energy devices. [more]
|
|
|
Wednesday, 14 Oct 2009
Patients receiving dronedarone for atrial fibrillation on top of adequate antithrombotic medication presented a significantly lower incidence of stroke, according to Stefan Hohnloser. [more]
|
|
|
Wednesday, 14 Oct 2009
We have many drugs available to us that could eventually come to clinical trials, but there are very few studies ongoing at the moment, John Camm said at the Venice Arrhythmias symposium. [more]
|
|
|
Monday, 12 Oct 2009
The clinical trial, sponsored by Boston Scientific, was designed to determine which programming strategy best minimises the occurrence of unnecessary therapy in ICD and CRT-D patients. [more]
|
|
|
Friday, 09 Oct 2009
Isolation of the pulmonary vein antrum and the superior vena cava using intracardiac echocardiography and circular mapping can achieve encouraging cure rates. [more]
|
|
|
Wednesday, 07 Oct 2009
Cardiologist, professor of Medicine at the University of Rochester Medical Center, USA, led studies that have changed medical guidelines. [more]
|
|
|
Monday, 28 Sep 2009
The European Medicines Agency has adopted a positive opinion recommending the grant of a marketing authorisation for Multaq (dronedarone, 400mg tablets). [more]
|
|
|
|
Wednesday, 23 Sep 2009
Asymptomatic or mildly symptomatic cardiac patients randomised to an implanted CRT-D have a 34% lower risk of heart failure or death than those receiving a standard ICD. [more]
|
|
|
Monday, 21 Sep 2009
AF Stat Call to Action for Atrial Fibrillation report cites limited understanding, disconnected dialogue and uncoordinated care as key barriers to improved outcomes. [more]
|
|
|
|
